200 related articles for article (PubMed ID: 15671263)
41. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy.
El-Ghrably IA; Dua HS; Orr GM; Fischer D; Tighe PJ
Br J Ophthalmol; 2001 Apr; 85(4):461-70. PubMed ID: 11264138
[TBL] [Abstract][Full Text] [Related]
42. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma.
Cassoux N; Giron A; Bodaghi B; Tran TH; Baudet S; Davy F; Chan CC; Lehoang P; Merle-Béral H
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3253-9. PubMed ID: 17591896
[TBL] [Abstract][Full Text] [Related]
43. Intraocular (vitreoretinal) lymphoma with renal, pelvic, and central nervous system lesions.
Bhatt N; Fox A; Chan CC; Roschewski M; Sen HN
Can J Ophthalmol; 2014 Aug; 49(4):e104-6. PubMed ID: 25103663
[No Abstract] [Full Text] [Related]
44. Increased expression of chemokine KC, an interleukin-8 homologue, in a model of oxygen-induced retinopathy.
Powers MR; Davies MH; Eubanks JP
Curr Eye Res; 2005 Apr; 30(4):299-307. PubMed ID: 16020260
[TBL] [Abstract][Full Text] [Related]
45. Intraocular chemotherapy for vitreoretinal lymphoma: A review.
Kvopka M; Lake SR; Smith JR
Clin Exp Ophthalmol; 2020 Mar; 48(2):240-248. PubMed ID: 31680408
[TBL] [Abstract][Full Text] [Related]
46. Atypical presentation of primary intraocular lymphoma.
Komatsu K; Sakai T; Kaburaki T; Tsuji H; Tsuneoka H
BMC Ophthalmol; 2016 Oct; 16(1):171. PubMed ID: 27716122
[TBL] [Abstract][Full Text] [Related]
47. Cytokine profiles and inflammatory cells during HSV-1-induced acute retinal necrosis.
Zheng M; Atherton SS
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1356-63. PubMed ID: 15790902
[TBL] [Abstract][Full Text] [Related]
48. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
Chan CC; Rubenstein JL; Coupland SE; Davis JL; Harbour JW; Johnston PB; Cassoux N; Touitou V; Smith JR; Batchelor TT; Pulido JS
Oncologist; 2011; 16(11):1589-99. PubMed ID: 22045784
[TBL] [Abstract][Full Text] [Related]
49. [A clinical study of intraocular malignant lymphoma].
Ohta A; Ebihara N; Hiratsuka Y; Yokoyama T; Murakami A; Oshimi K
Nippon Ganka Gakkai Zasshi; 2006 Aug; 110(8):588-93. PubMed ID: 16972650
[TBL] [Abstract][Full Text] [Related]
50. Functional expression of B7H1 on retinal pigment epithelial cells.
Usui Y; Okunuki Y; Hattori T; Kezuka T; Keino H; Ebihara N; Sugita S; Usui M; Goto H; Takeuchi M
Exp Eye Res; 2008 Jan; 86(1):52-9. PubMed ID: 17981268
[TBL] [Abstract][Full Text] [Related]
51. [Primary intraocular lymphoma].
Coupland SE; Heimann H
Ophthalmologe; 2004 Jan; 101(1):87-98. PubMed ID: 14986704
[TBL] [Abstract][Full Text] [Related]
52. Primary vitreoretinal natural killer/T-cell lymphoma with breast involvement: A case report and review of the literature.
Gao S; Zhou Y; Jin X; Lin Z; Zhong Y; Shen X
Surv Ophthalmol; 2019; 64(2):225-232. PubMed ID: 30321569
[TBL] [Abstract][Full Text] [Related]
53. [Intraocular lymphoma associated with primary malignant lymphoma of the central nervous system: Seven-year experience of a tertiary center].
Joubert R; Bonnin N; Kemeny JL; Moluçon-Chabrot C; Tournilhac O; Bacin F; Chiambaretta F
J Fr Ophtalmol; 2015 Jun; 38(6):559-66. PubMed ID: 25976140
[TBL] [Abstract][Full Text] [Related]
54. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
55. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro.
Martini B
Acta Ophthalmol Suppl (1985); 1992; (201):1-63. PubMed ID: 1322004
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation.
Itaya M; Sakurai E; Nozaki M; Yamada K; Yamasaki S; Asai K; Ogura Y
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5677-83. PubMed ID: 18055819
[TBL] [Abstract][Full Text] [Related]
57. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
58. Primary intraocular lymphoma: improving the diagnostic procedure.
Karma A; von Willebrand EO; Tommila PV; Paetau AE; Oskala PS; Immonen IJ
Ophthalmology; 2007 Jul; 114(7):1372-7. PubMed ID: 17324466
[TBL] [Abstract][Full Text] [Related]
59. Retina-derived fetuin (RDF): analysis by immunocytochemistry, reverse transcriptase-polymerase chain reaction and Southern blot.
Sheedlo HJ; Krishnamoorthy RS; Nelson TS; Agarwal NS; Liu JS; Roque RS; Wordinger RJ; Jaynes CD; Brun-Zinkelnagel AM; O'Brian P; Aschenbrenner JE; Turner JE
Curr Eye Res; 1999 Dec; 19(6):465-71. PubMed ID: 10550787
[TBL] [Abstract][Full Text] [Related]
60. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
Yoshida M; Takeuchi M; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
